|
Clinical impact of molecular tumor profiling in pediatric, adolescent, and young adult patients with extra-cranial solid malignancies: An interim report from the GAIN/iCat2 study. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Jazz Pharmaceuticals |
Consulting or Advisory Role - Jazz Pharmaceuticals |
| |
|
Consulting or Advisory Role - Bayer; Cellectis; Lilly; Loxo; Novartis |
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); Foundation Medicine (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - GE Healthcare; Johnson & Johnson; Varian Medical Systems |
Consulting or Advisory Role - Ymabs Therapeutics Inc |
Research Funding - Bayer (Inst); Ignyta (Inst); Lilly (Inst); Merck (Inst); Roche (Inst) |
Patents, Royalties, Other Intellectual Property - Patent for non-invasive methods of leukemia cell detection with MRI/MRS - Patent No. 8894975 |
| |
|
Consulting or Advisory Role - Fennec Pharma |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Bayer (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Roche/Genentech (Inst) |
Patents, Royalties, Other Intellectual Property - Patent on a T lympboblastic lymphoma cell line, CUTLL1 |
Travel, Accommodations, Expenses - Amgen (Inst) |
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Merck; SpringWorks Therapeutics |
| |
|
Stock and Other Ownership Interests - Litmus Health |
Consulting or Advisory Role - Accordant |
Travel, Accommodations, Expenses - Sanford Health |
| |
|
Consulting or Advisory Role - Bayer |
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst) |
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals |
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc |
| |
|
Consulting or Advisory Role - ArQule; Jubilant Radiopharma |
Research Funding - Agios; Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis |
Travel, Accommodations, Expenses - ArQule |
| |
|
Honoraria - Foundation Medicine |
Consulting or Advisory Role - Bayer; Ipsen; Ipsen |
Travel, Accommodations, Expenses - Bayer |